• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Model Number BXA117901A
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/06/2020
Event Type  malfunction  
Event Description
On (b)(6) 2020, the patient underwent aortoiliac stenosis repair using gore® excluder® iliac branch endoprosthesis (ibe) and extend into common iliac with gore® viabahn® vbx balloon expandable endoprosthesis (vbx).The vbx met significant resistance passing through an 8fr terumo sheath, but was eventually in proper position and successfully deployed.When removing the vbx balloon catheter through the same sheath, we again met resistance even while pulling negative pressure on the balloon.The vbx catheter detached into multiple pieces.The sheath and catheter were pulled out in tandem, and another sheath was reinserted.The patient did not appear to suffer an adverse effect.
 
Manufacturer Narrative
A review of the manufacturing records indicated the lot met all pre-release specifications.The device was identified to be an 11 x 79 x 800 mm configuration, which matches the event description.The device arrived with an introducer sheath; however, because this is not a gore product it was not evaluated (mpdcase-00000184_engineering_image_1).The gore® viabahn® vbx balloon expandable delivery system returned without the endoprosthesis mounted on it because it was successfully deployed; however, the returned hub had separated catheter material making it detached from the rest of the delivery system (mpdcase-00000184_engineering_image_2).The delivery catheter displayed necking from the separation point to 0.5 cm, 1.5-4 cm, 5-6 cm, and damage from 31-31.5cm.The manufacturing process output of device profile can contribute to insertion difficulties.Device profile is 100% inspected during the manufacturing process.The device history file did not indicate any anomalies occurred that would alter the device profile.The delivery catheter lot met specifications for tensile strength.Based on the device evaluation performed, no manufacturing anomalies were identified to which the event could be definitively attributed.H6 evaluation codes - results and conclusions updates to reflect the evaluations that were performed.
 
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium apl, which in covalently bound to the device surface and is essentially|non-eluting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10317398
MDR Text Key200427648
Report Number2017233-2020-01047
Device Sequence Number1
Product Code PRL
UDI-Device Identifier00733132637751
UDI-Public00733132637751
Combination Product (y/n)Y
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 02/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/14/2023
Device Model NumberBXA117901A
Device Catalogue NumberBXA117901A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/13/2020
Initial Date Manufacturer Received 07/06/2020
Initial Date FDA Received07/23/2020
Supplement Dates Manufacturer Received12/15/2020
02/25/2021
Supplement Dates FDA Received12/16/2020
02/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age62 YR
-
-